首页 | 本学科首页   官方微博 | 高级检索  
     

唑来膦酸治疗骨转移癌疼痛的临床研究
引用本文:王玉名,商冠宁,孙平. 唑来膦酸治疗骨转移癌疼痛的临床研究[J]. 中国民康医学, 2010, 22(2): 97-97,176. DOI: 10.3969/j.issn.1672-0369.2010.02.003
作者姓名:王玉名  商冠宁  孙平
作者单位:辽宁省肿瘤医院骨软组织外科,辽宁,沈阳,110042
摘    要:目的:探讨唑来膦酸治疗骨转移癌的临床疗效。方法:选择辽宁省肿瘤医院2006年8月至2009年3月门诊及住院骨转移癌患者85例,均用药3周期后评价疗效。结果:局部疼痛控制cR52例(61.2%),PR22例(25.9%),总有效率为87.1%;活动能力改善情况显效49例(57.6%),有效18例(21.2%),总有效率78.8%;不良反应13例,占15.3%。结论:唑来膦酸可明显提高骨转移癌患者局部疼痛缓解率,延长局部疼痛缓解时间,提高生命质量。

关 键 词:唑来膦酸  双膦酸盐  骨转移癌

Clinical research of zoledronic acid in the treatment for bone pain with bone metastusis
WANG Yu-ming,SHANG Guan-ning,SUN Ping. Clinical research of zoledronic acid in the treatment for bone pain with bone metastusis[J]. medical journal of chinese peoples health, 2010, 22(2): 97-97,176. DOI: 10.3969/j.issn.1672-0369.2010.02.003
Authors:WANG Yu-ming  SHANG Guan-ning  SUN Ping
Affiliation:WANG Yu-ming,SHANG Guan-ning,SUN Ping (Bone Soft Tissue Department of Surgery,Liaoning Cancer Hospital,Shenyang 110042,China)
Abstract:Objective:To investigate the clinical treatment for bone pain by zoledronic acid.Methods:Clinical data of 85 patients with bone metastusis treated from August 2006 to March 2009 were retrospectively analyzed after treated by zoledronic acid 3 cycles.Results:The relieve pain CR rate were 61.1%(52/85),the relieve pain PR rate were 25.8%(22/85),the total effect rate were 87.1%.The improve of activity marked rate were 57.6%(49/85),The improve of activity commonly rate were 21.1%(18/85),the total effect rate wer...
Keywords:Zoledronic acid  Bisphosphonates  Bone metastusis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号